OncoFactory is a biotech offering unique, innovative and predictive patient-derived xenograft models in oncology
We create replicas of patient tumors in a fast and powerful in vivo model, suited for all types of cancers. Tumors are analyzed using 3D imaging. Replicas can be collected back for a range of molecular analysis.
Using our technological platform we can:
– evaluate the efficacy of your therapeutic candidates on representative samples of the population of patients
– help you in the design of combi-therapies through a dedicated program integrating analysis of tumor responses to the candidate therapy and characterization of candidate therapy-induced activated signaling pathways
– characterize the mechanisms of action of your candidate therapies
-identify biomarkers to stratify the population of patients, predict the resistance
Take advantage of our services for:
– Discovery and early screening
– Preclinical efficacy and lead validation
– Translational biomarker Discovery
– Mimic of conditions of clinical trials
– Characterization of the mode of action of your candidate molecules
Cancer types successfully replicated in our model:
Breast cancer
Melanoma
Prostate cancer
Pancreatic cancer
Lung cancer
Liver cancer
Glioma
Glioblastoma
Neuroblastoma
Germ Cell tumor
Oncofactory can design custom-made models and experimental programs adapted to the needs and specifities of clients. Please contact us to discuss your project.
Events
Oncofactory presents a poster at the 4th international cancer symposium in Lyon
Partnership with Calym Carnot Institute
Oncofactory presents its technology at Matwin Convention in Bordeaux
Scientific papers
51th meeting of the European Pancreatic Club in Bergen
Selected publications of the scientific founders since 2010
